Medco Will Buy PolyMedica In $1.5 Billion Deal
This article was originally published in The Gray Sheet
Executive Summary
The pharmacy benefit manager Medco is expanding its foothold in the diabetes market with the $1.5 billion purchase of PolyMedica, a direct-to-consumer provider of diabetes supplies and services. The companies announced the definitive all-cash agreement Aug. 28 and expect the deal to close later this year